210 related articles for article (PubMed ID: 2158362)
1. Conformation-activity relationships of cyclic dermorphin analogues.
Wilkes BC; Schiller PW
Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
[TBL] [Abstract][Full Text] [Related]
2. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
Wilkes BC; Schiller PW
Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
Schiller PW; Nguyen TM; Maziak LA; Wilkes BC; Lemieux C
J Med Chem; 1987 Nov; 30(11):2094-9. PubMed ID: 2822930
[TBL] [Abstract][Full Text] [Related]
4. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
5. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
Shenderovich MD; Nikiforovich GV; Golbraikh AA
Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
[TBL] [Abstract][Full Text] [Related]
6. A conformational comparison of two stereoisomeric cyclic dermorphin analogues employing NMR and computer simulations.
Mierke DF; Schiller PW; Goodman M
Biopolymers; 1990; 29(6-7):943-52. PubMed ID: 2369622
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
Chao TM; Perez JJ; Loew GH
Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
[TBL] [Abstract][Full Text] [Related]
10. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
12. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
13. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
14. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.
Nikiforovich GV; Hruby VJ
Biochem Biophys Res Commun; 1990 Dec; 173(2):521-7. PubMed ID: 1979733
[TBL] [Abstract][Full Text] [Related]
15. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246
[TBL] [Abstract][Full Text] [Related]
17. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
18. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T
Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595
[TBL] [Abstract][Full Text] [Related]
19. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
